Get started
Ovid Therapeutics Inc.Ovid Therapeutics Inc.Ovid Therapeutics Inc.

Ovid Therapeutics Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

OVID chart


Full chart

OVID upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪20.51 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.3728 USD
Net income (FY)
‪−26.43 M‬ USD
Revenue (FY)
‪566.00 K‬ USD
Shares float
‪56.63 M‬
Beta (1Y)
2.07

Employees


Employees (FY)
23
Change (1Y)
−17 −42.50%
Revenue / Employee (1Y)
‪24.61 K‬ USD
Net income / Employee (1Y)
‪−1.15 M‬ USD

About Ovid Therapeutics Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Jeremy Max Levin
Website
ovidrx.com
Headquarters
New York
Founded
2014
FIGI
BBG009F0TD76
Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During on April 1, 2014 and is headquartered in New York, NY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

OVID news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as OVID.

Frequently Asked Questions


The current price of OVID is 0.2886 USD — it has increased by 6.53% in the past 24 hours. Watch Ovid Therapeutics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Ovid Therapeutics Inc. stocks are traded under the ticker OVID.
OVID stock has risen by 3.07% compared to the previous week, the month change is a −38.60% fall, over the last year Ovid Therapeutics Inc. has showed a −90.92% decrease.
We've gathered analysts' opinions on Ovid Therapeutics Inc. future price: according to them, OVID price has a max estimate of 4.00 USD and a min estimate of 2.00 USD. Watch OVID chart and read a more detailed Ovid Therapeutics Inc. stock forecast: see what analysts think of Ovid Therapeutics Inc. and suggest that you do with its stocks.
OVID reached its all-time high on May 18, 2017 with the price of 15.9290 USD, and its all-time low was 0.2425 USD and was reached on Apr 9, 2025. View more price dynamics on OVID chart.
See other stocks reaching their highest and lowest prices.
OVID stock is 7.46% volatile and has beta coefficient of 2.07. Track Ovid Therapeutics Inc. stock price on the chart and check out the list of the most volatile stocks — is Ovid Therapeutics Inc. there?
Today Ovid Therapeutics Inc. has the market capitalization of ‪20.51 M‬, it has increased by 2.73% over the last week.
Yes, you can track Ovid Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
Ovid Therapeutics Inc. is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
OVID earnings for the last quarter are −0.13 USD per share, whereas the estimation was −0.17 USD resulting in a 22.93% surprise. The estimated earnings for the next quarter are −0.14 USD per share. See more details about Ovid Therapeutics Inc. earnings.
Ovid Therapeutics Inc. revenue for the last quarter amounts to ‪76.00 K‬ USD, despite the estimated figure of ‪190.38 K‬ USD. In the next quarter, revenue is expected to reach ‪74.67 K‬ USD.
OVID net income for the last quarter is ‪−9.25 M‬ USD, while the quarter before that showed ‪−14.01 M‬ USD of net income which accounts for 33.94% change. Track more Ovid Therapeutics Inc. financial stats to get the full picture.
No, OVID doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 19, 2025, the company has 23 employees. See our rating of the largest employees — is Ovid Therapeutics Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ovid Therapeutics Inc. EBITDA is ‪−61.28 M‬ USD, and current EBITDA margin is ‪−10.83 K‬%. See more stats in Ovid Therapeutics Inc. financial statements.
Like other stocks, OVID shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ovid Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ovid Therapeutics Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ovid Therapeutics Inc. stock shows the sell signal. See more of Ovid Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.